Ignite Creation Date:
2025-12-25 @ 12:43 AM
Ignite Modification Date:
2026-01-06 @ 6:46 AM
Study NCT ID:
NCT03850067
Status:
COMPLETED
Last Update Posted:
2024-08-26
First Post:
2019-02-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Safety, Tolerability and Preliminary Efficacy Evaluation of CC-90011 Given in Combination With Cisplatin and Etoposide in Subjects With First Line, Extensive Stage Small Cell Lung Cancer
Sponsor:
Celgene
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-03-12
Start Date Type:
ACTUAL
Primary Completion Date:
2024-07-16
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-07-16
Completion Date Type:
ACTUAL
First Submit Date:
2019-02-20
First Submit QC Date:
None
Study First Post Date:
2019-02-21
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-08-23
Last Update Post Date:
2024-08-26
Last Update Post Date Type:
ACTUAL